Please try another search
Shanghai Kaibao Pharmaceutical CO.,Ltd. is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent drugs. The Company's main product is Tanreqing injection, which is used for treatment of upper respiratory tract infections, such as cold and pneumonia. The Company's products include injections, tablets, capsules, granules, vinum and pills, among others. The Company distributes its products in domestic markets.
Name | Age | Since | Title |
---|---|---|---|
Shaoyong Liu | - | - | Supervisor |
Shaoyong Liu | 58 | 2014 | Chairman of the Supervisory Board |
Liwang Ren | 54 | 2008 | Board Secretary & Non-Independent Director |
Dongsheng Xue | 54 | 2011 | Shareholder Supervisor |
Yingbin Zhou | 46 | 2020 | Deputy GM & Director |
Zhengni Li | 49 | 2020 | Independent Director |
Zuguang Ye | 77 | 2020 | Independent Director |
Keji Zhao | 41 | 2017 | Shareholder Representing Supervisor |
Shuzhong Jing | - | 2023 | Non-Independent Director |
Jianzhong Liu | - | 2023 | Non-Independent Director |
Jingwei Mu | 45 | 2014 | Chairman |
Ningbo Zhao | 45 | 2017 | Non-Independent Director |
Hong Ma | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review